Genomics Market Anticipated to Reach USD 126.8 Billion by 2033, Growing at a Steady CAGR of 10.5% Over Forecast Period

Genomics Market is the study of genes and their functions. The genomics market is expected to grow in the coming years as the technology becomes more affordable and accessible.

Products in the genomics market include sequencing, microarrays, and PCR. Sequencing is the most popular product, accounting for over half of the market share. Microarrays are used for gene expression and SNP analysis, while PCR is used for DNA amplification and sequencing.

The global Genomics Market was valued at US$ 45.9 billion in 2023 and it is anticipated to grow up to US$ 126.8 billion by 2033, at a CAGR of 10.5% during the forecast period.

Download Research Report Sample & TOC:
https://www.globalinsightservices.com/request-sample/GIS20110/

(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution and Potential)

  • 11 – Chapter
  • 319 – Pages
  • Industry: Pharmaceuticals

Key trends:

The key trends in the genomics market are the increasing demand for personalized medicine and the increasing funding for genomics research.

Get Customized Reports with your Requirements:
https://www.globalinsightservices.com/request-customization/GIS20110

Market Segmentation:

By Type:

The market is classified into functional genomics, biomarker discovery, pathway analysis, epigenomics, and others. The epigenomics segment dominated the market in 2023 in terms of revenue and is expected to dominate the market during the forecast period.

By Application:

The Genomics Market is segmented into drug discovery & development, diagnostics, agriculture & animal research, and others. The drug discovery & development segment is expected to dominate the market during the forecast period.

Inquiry before Buying: 
https://www.globalinsightservices.com/inquiry-before-buying/GIS20110

Data Summary:

Report Attribute

Details

Market Size in 2023 USD 45.9 Billion
Market Size in 2033 USD 126.8 Billion
Growth Rate (2024-33) 10.5%
Historic Period 2017-2022
Forecast Period 2024-2033
Base Year 2023
Segments Covered Technology, Application, Product & Services, Study Type, End-Use, and Region
Key Companies Oxford Nanopore Technologies (U.K), Danaher Corporation (U.S), Thermo Fisher Scientific Inc. (U.S), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina Inc. (U.S), Bio-Rad Laboratories (U.S), Agilent Technologies (U.S), Eppendorf (Germany), GE Healthcare Inc. (U.S), among others.
Regional Scope North America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis Coverage Market Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments

Research Scope:

  • The report offers a comprehensive quantitative as well as qualitative analysis of the current Genomics Market outlook and estimations from 2023 to 2033, which helps to recognize the prevalent opportunities.
  • The report also covers qualitative as well as quantitative analysis of the Genomics Market in terms of revenue ($Million) and volume (Units).
  • Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Genomics industry.
  • A thorough analysis of market trends and restraints is provided.
  • By region as well as country, market analysis is also presented in this report.
  • The Genomics Market Study comprises an analysis of 23 countries. The research also encompasses a segment analysis of every country in terms of value (USD Million) throughout the study period.
  • Analytical depiction of the Genomics Market along with current trends and future estimations to depict imminent investment pockets. The overall Genomics industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
  • Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Genomics Market are also analyzed.
  • The report also involves market strategy factors such as the ANSOFF Matrix, 4Ps Model, Demand-Supply Analysis, Competition Product Analysis, Recent Developments, Consumer Buying Interest, and Supply Chain Analysis among others.

Procure Complete Report (319 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.globalinsightservices.com/checkout/single_user/GIS20110

Key Players:

  • Oxford Nanopore Technologies (U.K)
  • Danaher Corporation (U.S)
  • Thermo Fisher Scientific Inc. (U.S)
  • Eurofins Scientific (Luxembourg)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Illumina Inc. (U.S)
  • Bio-Rad Laboratories (U.S)
  • Agilent Technologies (U.S)
  • Eppendorf (Germany)
  • GE Healthcare Inc. (U.S)

By Region

  • North America  (U.S., Canada, Mexico)
  • Europe  (UK, Germany, France, Italy, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Rest of Asia-Pacific)
  • Latin America  (Brazil, Argentina, Rest of Latin America)
  • Middle East and Africa  (UAE, Saudi Arabia, Rest of Middle East And Africa)

With Global Insight Services, you receive:

  • 10-year forecast to help you make strategic decisions
  • In-depth segmentation which can be customized as per your requirements
  • Free consultation with lead analyst of the report
  • Infographic excel data pack, easy to analyze big data
  • Robust and transparent research methodology
  • Unmatched data quality and after sales service

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Us:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.